Assessment of the Safety and Performance of a Compression Ankle Support in the Prevention of Injuries During Sports Practice
1 other identifier
interventional
30
1 country
4
Brief Summary
Decathlon has developed ankleSOFT100 product which is medical device designed to reduce pain and joint instability during sport practice. The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon ankleSOFT100 product to demonstrate safety and performance of this device in a real-world setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started Mar 2021
Typical duration for not_applicable chronic-pain
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2021
CompletedStudy Start
First participant enrolled
March 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedSeptember 14, 2022
September 1, 2022
2.1 years
September 4, 2020
September 12, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Functional score
Change from baseline functional result (Cumberland Ankle Instability Tool: 0-30 points) at 6 weeks
At baseline and 6 weeks of follow-up
Secondary Outcomes (4)
Confidence level
At baseline and 6 weeks of follow-up
Ankle instability
At 2 weeks and 6 weeks of follow-up
Ankle pain
At 2 weeks and 6 weeks of follow-up
Safety (adverse events)
6 weeks of follow-up
Study Arms (1)
Orthosis group
EXPERIMENTALInterventions
During the first two weeks of follow-up, the subject shall not use the device during the sports sessions. The subject shall use the device during the sports sessions for the next 4 weeks (6 weeks of follow-up)
Eligibility Criteria
You may qualify if:
- Subject is aged ≥18 years old
- Subject has chronic pain AND / OR chronic ankle instability
- The current condition of his/her ankle allows the subject to pursue a usual physical activity
- Subject has been informed and is willing to sign an informed consent form
- Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (6 weeks)
- Subject is affiliated to the French social security regime
- Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent
- Subject has worn a support (ankle brace or articulated orthosis) during sports sessions during the last month
- Subject has any medical condition that could impact the study at investigator's discretion
- Subject has a known hypersensitivity or allergy to the components of the device (polyamide, elastodiene, elastane, polyester, synthetic rubber)
- Adult subject to a legal protection measure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Decathlon SElead
- EFOR, Francecollaborator
Study Sites (4)
Centre de rééducation et de balnéothérapie Kinés Faches
Faches-Thumesnil, 59155, France
Centre Hospitalier Universitaire de Lille
Lille, 59000, France
Cabinet de kinésithérapie du Belvédère
Paris, 75019, France
KOSS Paris 8
Paris, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valérie WIECZOREK
Centre Hospitalier Universitaire de Lille
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2020
First Posted
February 5, 2021
Study Start
March 17, 2021
Primary Completion
May 1, 2023
Study Completion
May 1, 2023
Last Updated
September 14, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share